Market snapshot: Oct 12, 2026, 3:00 AM UTC. Prices may have changed since this snapshot.

GroupPOLYMARKET

Event GroupPOLYMARKETSports

NK Celje vs. AS Omónoia Leukosías - Exact Score

Name: NK Celje vs. AS Omónoia Leukosías - Exact Score
End: 2026-10-15T16:45:00.000Z

Total Volume

$18.07K

Events

Markets

Trade on Polymarket

NK Celje vs. AS Omónoia Leukosías - Exact Score

Vol

$18.07K

Events

Markets

Polymarket

Platform StatsQuick Platform Comparison

Polymarket

markets · $18.07K

Kalshi

markets · $0.00

Price Spread

0.0%avg

max 0.0%

Arbitrage

of 0 cross-platform

Volume DistributionTotal: $18.07K

100%

Polymarket leads

Price ChartMatched Markets Price Graph

37 markets tracked

Exact Score: NK Celje 3 - 1 AS Omónoia Leukosías?

No data available

Single-Platform Markets(37)

Market	Platform	Price
Exact Score: NK Celje 3 - 1 AS Omónoia Leukosías?	Poly	25%
Exact Score: NK Celje 3 - 5 AS Omónoia Leukosías?	Poly	24%
Exact Score: NK Celje 5 - 4 AS Omónoia Leukosías?	Poly	24%
Exact Score: NK Celje 5 - 0 AS Omónoia Leukosías?	Poly	23%
Exact Score: NK Celje 4 - 1 AS Omónoia Leukosías?	Poly	22%
Exact Score: NK Celje 5 - 1 AS Omónoia Leukosías?	Poly	22%
Exact Score: NK Celje 3 - 4 AS Omónoia Leukosías?	Poly	20%
Exact Score: NK Celje 0 - 4 AS Omónoia Leukosías?	Poly	20%
Exact Score: NK Celje 4 - 0 AS Omónoia Leukosías?	Poly	20%
Exact Score: NK Celje 5 - 3 AS Omónoia Leukosías?	Poly	19%
Exact Score: Any Other Score?	Poly	17%
Exact Score: NK Celje 1 - 4 AS Omónoia Leukosías?	Poly	17%
Exact Score: NK Celje 0 - 3 AS Omónoia Leukosías?	Poly	17%
Exact Score: NK Celje 4 - 3 AS Omónoia Leukosías?	Poly	16%
Exact Score: NK Celje 1 - 5 AS Omónoia Leukosías?	Poly	16%
Exact Score: NK Celje 0 - 5 AS Omónoia Leukosías?	Poly	14%
Exact Score: NK Celje 4 - 5 AS Omónoia Leukosías?	Poly	14%
Exact Score: NK Celje 1 - 1 AS Omónoia Leukosías?	Poly	13%
Exact Score: NK Celje 2 - 1 AS Omónoia Leukosías?	Poly	9%
Exact Score: NK Celje 0 - 1 AS Omónoia Leukosías?	Poly	9%
Exact Score: NK Celje 1 - 0 AS Omónoia Leukosías?	Poly	9%
Exact Score: NK Celje 1 - 2 AS Omónoia Leukosías?	Poly	9%
Exact Score: NK Celje 0 - 0 AS Omónoia Leukosías?	Poly	7%
Exact Score: NK Celje 2 - 2 AS Omónoia Leukosías?	Poly	7%
Exact Score: NK Celje 2 - 0 AS Omónoia Leukosías?	Poly	6%
Exact Score: NK Celje 0 - 2 AS Omónoia Leukosías?	Poly	6%
Exact Score: NK Celje 3 - 0 AS Omónoia Leukosías?	Poly	5%
Exact Score: NK Celje 1 - 3 AS Omónoia Leukosías?	Poly	4%
Exact Score: NK Celje 2 - 5 AS Omónoia Leukosías?	Poly	4%
Exact Score: NK Celje 5 - 5 AS Omónoia Leukosías?	Poly	4%
Exact Score: NK Celje 4 - 2 AS Omónoia Leukosías?	Poly	4%
Exact Score: NK Celje 2 - 3 AS Omónoia Leukosías?	Poly	3%
Exact Score: NK Celje 3 - 2 AS Omónoia Leukosías?	Poly	3%
Exact Score: NK Celje 3 - 3 AS Omónoia Leukosías?	Poly	3%
Exact Score: NK Celje 5 - 2 AS Omónoia Leukosías?	Poly	3%
Exact Score: NK Celje 2 - 4 AS Omónoia Leukosías?	Poly	3%
Exact Score: NK Celje 4 - 4 AS Omónoia Leukosías?	Poly	3%

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

25%

Top Probability

$18.07K

Volume

Markets

Platforms

About This Event

In the upcoming UEFA Europa League game between NK Celje and AS Omónoia Leukosías, scheduled for October 15, 2026 at 12:45 PM ET: This market will resolve based on the final score of the NK Celje vs. AS Omónoia Leukosías match originally scheduled for October 15, 2026 at 12:45 PM ET, considering only the result at the end of 90 minutes of regulation plus stoppage time; extra time and penalty shoot-outs are excluded. If the actual score is not one of the explicitly listed outcomes, the market res

AI-generated analysis based on market data. Not financial advice.

Custom AI Analysis Prompt

Tap to expand

Open in:ChatGPT Claude Gemini Grok DeepSeek

**Role:** Expert Prediction Market Analyst & Trader
**Objective:** Analyze the provided betting market data to deliver actionable insights, identify mispricings, and perform scenario analysis.
**Current Date:** Monday, October 12, 2026
**Context:** Prediction markets (Polymarket/Kalshi) are binary option markets where price (1-99) equals implied probability (1%-99%).

---

## 1. Event Snapshot
**Event:** NK Celje vs. AS Omónoia Leukosías - Exact Score
**Category:** Sports | **Status:** active
**Resolution Date:** Oct 15, 2026 (4 days left)
**Time Pressure:** High

**Description:** In the upcoming UEFA Europa League game between NK Celje and AS Omónoia Leukosías, scheduled for October 15, 2026 at 12:45 PM ET: This market will resolve based on the final score of the NK Celje vs. AS Omónoia Leukosías match originally scheduled for October 15, 2026 at 12:45 PM ET, considering only the result at the end of 90 minutes of regulation plus stoppage time; extra time and penalty shoot-outs are excluded. If the actual score is not one of the explicitly listed outcomes, the market res

**Resolution Criteria (Sample):**
"In the upcoming UEFA Europa League game between NK Celje and AS Omónoia Leukosías, scheduled for October 15, 2026 at 12:45 PM ET: This market will resolve based on the final score of the NK Celje vs. AS Omónoia Leukosías match originally scheduled for October 15, 2026 at 12:45 PM ET, considering onl"

## 2. Market liquidity & Volume
* **Total Volume:** $18.1K
* **Total Liquidity:** $53.6K
* **Activity Level:** Low Activity (Vol/Liq Ratio: 0.34)

## 3. Market Data (Prices & Odds)
### 1. Exact Score: NK Celje 0 - 0 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 6.5% (0.0%)] | [No: 93.5% (0.0%)]

### 2. Exact Score: NK Celje 0 - 1 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 8.5% (0.0%)] | [No: 91.5% (0.0%)]

### 3. Exact Score: NK Celje 1 - 0 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 8.5% (0.0%)] | [No: 91.5% (0.0%)]

### 4. Exact Score: NK Celje 0 - 2 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 5.8% (0.0%)] | [No: 94.3% (0.0%)]

### 5. Exact Score: NK Celje 1 - 1 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 12.5% (0.0%)] | [No: 87.5% (0.0%)]

### 6. Exact Score: NK Celje 2 - 0 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 6.1% (0.0%)] | [No: 93.9% (0.0%)]

### 7. Exact Score: NK Celje 0 - 3 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 16.7% (0.0%)] | [No: 83.4% (0.0%)]

### 8. Exact Score: NK Celje 1 - 2 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 8.5% (0.0%)] | [No: 91.5% (0.0%)]

### 9. Exact Score: NK Celje 2 - 1 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 9.0% (0.0%)] | [No: 91.0% (0.0%)]

### 10. Exact Score: NK Celje 3 - 0 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 4.9% (0.0%)] | [No: 95.2% (0.0%)]

### 11. Exact Score: NK Celje 0 - 4 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 20.2% (0.0%)] | [No: 79.8% (0.0%)]

### 12. Exact Score: NK Celje 1 - 3 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 4.0% (0.0%)] | [No: 96.0% (0.0%)]

### 13. Exact Score: NK Celje 2 - 2 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 6.5% (0.0%)] | [No: 93.5% (0.0%)]

### 14. Exact Score: NK Celje 3 - 1 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 24.9% (0.0%)] | [No: 75.0% (0.0%)]

### 15. Exact Score: NK Celje 4 - 0 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 19.9% (0.0%)] | [No: 80.1% (0.0%)]

### 16. Exact Score: NK Celje 0 - 5 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 14.5% (0.0%)] | [No: 85.5% (0.0%)]

### 17. Exact Score: NK Celje 1 - 4 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 16.8% (0.0%)] | [No: 83.3% (0.0%)]

### 18. Exact Score: NK Celje 2 - 3 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 3.5% (0.0%)] | [No: 96.5% (0.0%)]

### 19. Exact Score: NK Celje 3 - 2 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 3.5% (0.0%)] | [No: 96.5% (0.0%)]

### 20. Exact Score: NK Celje 4 - 1 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 21.8% (0.0%)] | [No: 78.2% (0.0%)]

### 21. Exact Score: NK Celje 5 - 0 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 22.5% (0.0%)] | [No: 77.5% (0.0%)]

### 22. Exact Score: NK Celje 1 - 5 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 15.5% (0.0%)] | [No: 84.5% (0.0%)]

### 23. Exact Score: NK Celje 2 - 4 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 3.4% (0.0%)] | [No: 96.6% (0.0%)]

### 24. Exact Score: NK Celje 3 - 3 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 3.5% (0.0%)] | [No: 96.5% (0.0%)]

### 25. Exact Score: NK Celje 4 - 2 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 4.0% (0.0%)] | [No: 96.0% (0.0%)]

### 26. Exact Score: NK Celje 5 - 1 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 21.5% (0.0%)] | [No: 78.5% (0.0%)]

### 27. Exact Score: NK Celje 2 - 5 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 4.0% (0.0%)] | [No: 96.0% (0.0%)]

### 28. Exact Score: NK Celje 3 - 4 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 20.3% (0.0%)] | [No: 79.7% (0.0%)]

### 29. Exact Score: NK Celje 4 - 3 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 16.4% (0.0%)] | [No: 83.5% (0.0%)]

### 30. Exact Score: NK Celje 5 - 2 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 3.5% (0.0%)] | [No: 96.5% (0.0%)]

### 31. Exact Score: NK Celje 3 - 5 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 24.0% (0.0%)] | [No: 76.0% (0.0%)]

### 32. Exact Score: NK Celje 4 - 4 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 2.9% (0.0%)] | [No: 97.1% (0.0%)]

### 33. Exact Score: NK Celje 5 - 3 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 18.5% (0.0%)] | [No: 81.5% (0.0%)]

### 34. Exact Score: NK Celje 4 - 5 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 14.5% (0.0%)] | [No: 85.5% (0.0%)]

### 35. Exact Score: NK Celje 5 - 4 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 24.0% (0.0%)] | [No: 76.0% (0.0%)]

### 36. Exact Score: NK Celje 5 - 5 AS Omónoia Leukosías?
- **Polymarket** (End: Oct 15, 2026): Vol $0
  DATA: [Yes: 4.0% (0.0%)] | [No: 96.0% (0.0%)]

### 37. Exact Score: Any Other Score?
- **Polymarket** (End: Oct 15, 2026): Vol $18.1K
  DATA: [Yes: 17.0% (0.0%)] | [No: 83.0% (0.0%)]

---

## Analysis Instructions
Please provide a structured analysis using the following template:

### 1. Executive Summary
*   **Verdict:** [Most Likely Outcome]
*   **Confidence:** [0-100]%
*   **Timeframe:** [Immediate / Short-term / Long-term]
*   **Actionable Trade:** [Buy YES / Buy NO / Stay Away] (Include entry price target if applicable)
*   **Rationale:** 2-sentence summary of the core thesis.

### 2. Scenario Analysis
*   **Bull Case (Why YES goes up):** List specific catalysts or data points.
*   **Bear Case (Why YES goes down):** List specifics.
*   **Invalidation Point:** What happens to prove your thesis wrong?

### 3. Market Mechanics & Risks
*   **Liquidity/Volume Analysis:** Is the market efficient? Is it easy to exit?
*   **Cross-Platform Arbitrage:** (If applicable) Is the spread tradeable after fees?
*   **Time Decay:** How does time passing affect this position?

### 4. Signal Scores (0-100)
*   **Momentum:** [Score] (Price trend & velocity)
*   **Conviction:** [Score] (Volume backing the move)
*   **Information Edge:** [Score] (Likelihood of non-public info affecting price)
*   **Risk/Reward:** [Score] (Potential upside vs downside)

**Constraints:**
- Be direct and objective.
- Use bullet points for readability.
- If data is conflicting or insufficient, explicitly state "Low Confidence".

Tap text to select all

Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

POLYMARKETSports